E-LIB Suche - Ergebnisse für: Marta Sobas

1

A hybrid protocol CLAG-M, a possible player for the first-l..:

Karasek, Magdalena ; Armatys, Anna ; Skarupski, Marek...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombot..:

Segura-Díaz, Adrián ; Stuckey, Ruth ; Florido, Yanira...
Thrombosis and Haemostasis. 124 (2024) 7 - p. 669-675 , 2024

Link: https://doi.org/10.1055/..

3

Advances in decision support for diagnosis and early manage..:

Turki, Amin T ; Engelke, Merlin ; Sobas, Marta
The Lancet Digital Health. 6 (2024) 5 - p. e300-e301 , 2024

Link: https://doi.org/10.1016/..

4

Rearrangements involving 11q23.3/KMT2A in adult AML: mutati..:

Hernández-Sánchez, Alberto ; González, Teresa ; Sobas, Marta...
Leukemia. , 2024

Link: https://doi.org/10.1038/..

5

Creutzfeldt-Jakob Disease as a Reason for Neurological Dete..:

Karasek, Magdalena ; Szmukala, Melissa ; Bladowska, Joanna...
Turkish Journal of Hematology. 40 (2023) 2 - p. 132-134 , 2023

Link: https://doi.org/10.4274/..

6

P491: DAY 14 MEASURABLE RESIDUAL DISEASE ASSESSMENT PREDICT..:

Wierzbowska, Agnieszka ; Pluta, Agnieszka ; Czyz, Anna...
HemaSphere. 7 (2023) S3 - p. e7224364 , 2023

Link: https://doi.org/10.1097/..

7

MPN-339 Outcomes of Patients With Myelofibrosis and Elevate..:

Vachhani, Pankit ; Scott, Bart ; Bose, Prithviraj...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S389-S390 , 2023

Link: https://doi.org/10.1016/..

8

Easily Applicable Predictive Score for Differential Diagnos..:

Lekovic, Danijela ; Bogdanovic, Andrija ; Sobas, Marta...
Cancers. 15 (2023) 16 - p. 4180 , 2023

Link: https://doi.org/10.3390/..

9

Incidence, risk factors, and outcomes of second neoplasms i..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
Annals of Hematology. 103 (2023) 2 - p. 451-461 , 2023

Link: https://doi.org/10.1007/..

10

P1053: NEUTROPHIL-TO-LYMPHOCYTE AND PLATELET-TO-LYMPHOCYTE ..:

Cvetkovic, Mirjana ; Ivanović, Jelena ; Arsenović, Isidora...
HemaSphere. 7 (2023) S3 - p. e64878ce , 2023

Link: https://doi.org/10.1097/..

11

P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLA..:

Sobas, Marta ; Knopinska-Posluszny, Wanda ; Piątkowska-Jakubas, Beata...
HemaSphere. 7 (2023) S3 - p. e835897e , 2023

Link: https://doi.org/10.1097/..

12

POSTER: MPN-339 Outcomes of Patients With Myelofibrosis and..:

Vachhani, Pankit ; Scott, Bart ; Bose, Prithviraj...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S193 , 2023

Link: https://doi.org/10.1016/..

13

High molecular risk variants, severe thrombocytopenia and l..:

Kanduła, Zuzanna ; Janowski, Michał ; Więckowska, Barbara...
Journal of Applied Genetics. 64 (2023) 3 - p. 479-491 , 2023

Link: https://doi.org/10.1007/..

14

Analysis of Predictive Factors for Early Response to Ruxoli..:

Góra-Tybor, Joanna ; Gołos, Aleksandra ; Mikulski, Damian...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 1 - p. e19-e26 , 2023

Link: https://doi.org/10.1016/..

15

Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibi..:

Pemmaraju, Naveen ; Harrison, Claire ; Gupta, Vikas...
eJHaem. 3 (2022) 4 - p. 1346-1351 , 2022

Link: https://doi.org/10.1002/..